The largest database of trusted experimental protocols

5 protocols using ab125687

1

Quantitative Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot assay was used to detect total caspase-3, plasminogen activator inhibitor 1 (PAI1), protein kinase B (PKB) commonly known as Akt, p-Akt, 3-nitrotyrosine, and glyceraldehyde phosphate dehydrogenase (GAPDH). After electrophoresis and transfer, the polyvinylidene fluoride membranes were rinsed briefly in Tris-buffered saline, blocked (5% skim milk or 0.5% bovine serum albumin (BSA)) for 1 hr, and washed 3 times with Tris-buffered saline containing 0.05% Tween 20 for 5 min. The membranes were then incubated with anti-caspase-3 (Abcam, ab2171), anti-PAI1 (Abcam, ab125687), anti-p-AKT (Abcam, EP2109Y), anti-AKT (Abcam, ab8805), or anti-3-nitrotyrosine (Abcam, ab61392) in conjunction with GAPDH (Abcam, ab181602) overnight before being washed as described previously and then reacted with horseradish peroxidase-conjugated antibody for 1 hr. Antigen-antibody complexes were visualized by an electrochemiluminescence (ECL) kit (Biotrand, Crystal Lake, Ilinois, US) (12 (link)), and protein levels were normalized to GAPDH.
+ Open protocol
+ Expand
2

Molecular Mechanisms of PAI-1 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against PAI-1 (ab222754, 1:500; ab125687, 1:100), anti-VTN (ab45139, 1:2000), anti-LRP1 (ab168454, WB 1:1000, IP 1:100), anti-SMAD2 (phosphor S467) (ab280888), anti-SMAD2(ab40855), anti-SMAD3 (phosphor S423+S425) (ab172202), anti-SMAD3 (AB40854) were purchased from Abcam. Anti-PLAT (sc-515562, 1:50) and anti-PLAU (sc-59727, 1:500) were purchased from Santa cruz. Anti- Phospho-STAT1 (Tyr701) (7649T), anti-STAT1 (14994T), anti-Phospho-p44/42 MAPK (Erk1/2) (Thr202/tyr204) (4370), anti p44/42 MAPK (Erk1/2) (4695), anti-Phospho-Akt (Ser473) (4060), anti-Akt (14702) anti-phospho-PI3 Kinase p85 (Tyr458)/p55 (Tyr199) (4228), anti-PI3 Kinase p85(4257), anti-E-Cadherin (3195T), anti-N-Cadherin (13116T), anti-phospho- NF-κB p65 (Ser536) (3033s), anti- NF-κB p65 (8242) were purchased from CST. Anti-Anti-GAPDH (10494-1-AP) was purchased from Proteintech. His tagged human PAI-1 (10296-H08H) was purchased from Sino Biological. His-PLAU (PLU-H5229) was purchased from Acro. Human Lys-plasminogen (HPG2002), Glu-plasminogen (HPG2001) and S-2251 (100-01) were purchased from Enzyme Research Laboratories. Z-GGR-AMC was purchased from A+ peptide (shanghai). Recombinant Human LRP1-Cluster II-Fc Chimera protein (2368-L2) was purchased from Bio-Techne.
+ Open protocol
+ Expand
3

Immunoblotting Protein Quantification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoblotting was done by a method as described previously [14 (link)]. Protein quantification was done by Bradford assay and equal quantity of protein was loaded onto each lane. The primary antibodies used in the study were mouse anti-α-SMA (ab7817, 1:1000, Abcam, Cambridge, MA, USA), anti-vimentin (D21H3, 1:1000, Cell Signalling Technology, Beverly, MA, USA) rabbit anti-fibronectin (AF5335, 1:1000, Affinity Biosciences, Brisbane, Queensland, Australia), mouse anti-fibulin-5 (ab66339, 1:800, Abcam, Cambridge, MA, USA), mouse anti-PAI-1 (ab125687, 1:1000, Abcam, Cambridge, MA, USA), rabbit anti-Fibrillin (AF0429, 1:1000, Affinity Biosciences, Brisbane, Queensland, Australia) and rabbit anti-pSMAD3(C25A9, 1:1000, Cell Signalling Technology, Beverly, MA, USA). Rabbit anti-GAPDH (1:10,000; Abcam, Cambridge, MA, USA) was used as the loading control.
+ Open protocol
+ Expand
4

STZ-Induced Diabetic Kidney Fibrosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco's modified Eagle's medium (DMEM) and foetal bovine serum (FBS) were from Gibco (Grand Island, NY). Streptozotocin (STZ) was obtained from Sigma Chemical (St. Louis, MO). Primary antibodies for immunohistochemistry and Western blot analyses included PTPN2 (ab180764; Abcam); P‐STAT1 (#9167; Cell Signaling); P‐STAT3 (#9145; Cell Signaling); Arginase I (16001‐1‐AP; Proteintech Group Inc); Arginase II (14825‐1‐AP; Proteintech Group Inc); CD11c (17342‐1‐AP; Proteintech Group Inc); CD206 (18704‐1‐AP; Proteintech Group Inc); F4/80 (27044‐1‐AP; Proteintech Group Inc); CD3 (17617‐1‐AP; Proteintech Group Inc); fibronectin (ab2413; Abcam); Collagen I (#84336; Cell Signaling); Collagen IV (ab6586; Abcam); TGF‐β (#3711; Cell Signaling); PAI‐1 (ab125687; Abcam); α‐SMA (#19245; Cell Signaling); MCP‐1(#2029; Cell Signaling); TNF‐α (ab6671; Abcam); IL‐6 (ab208113; Abcam); ICAM‐1 (ab171123; Abcam); vascular endothelial growth factor (VEGF; 19003‐1‐AP; Proteintech Group Inc); CD31 (#77699; Cell Signaling) and β‐actin (ab8226; Abcam). ELISA kits for MCP‐1 were from ab208979, Abcam.
+ Open protocol
+ Expand
5

Vein Endothelial Cell Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vein endothelial cells were homogenized in lysis buffer containing protease inhibitor and centrifuged at 8,000 rpm at 4°C for 10 min. The supernatant of the mixture was used for analysis of the relevant protein using sodium dodecyl sulfate (SDS) assay according to the manufacturer's instructions (26 (link)). The primary goat anti-rat antibodies [anti-TAFI (1:1,000; ab181990), anti-PAI-1 (1:1,000; ab125687), anti-vWF (1:1,000; ab6994), anti-ADP (1:1,000; ab22554), anti-MMP9 (1:1,000; ab73734), anti-NF-κB (1:1,000; ab32360) (all from Abcam, Cambridge, UK)] were added after blocking (5% skimmed milk) for 60 min at 37°C and then washing with PBS three times. Subsequently, incubation with the secondary rabbit anti-goat antibody (1:1,000; ab6741; Abcam, UK) was carried out for 24 h at 4°C. The results were visualized using a chemiluminescence detection system.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!